TCT 2018 | FAST-FFR: Angiography-Derived FFR Without Hyperemic Stimulus or Invasive Guidewire Placement

All over the world, functional lesion measurement remains underutilized due to the need for a hyperemic stimulus (which may be avoided with instantaneous wave-free ratio [iFR]) and, above all, the invasiveness of guidewire placement (crossing the intended lesion) for the measurement. These guidewires have improved a lot, but they still lack the navigating capacity of the workhorse guidewires we often choose.

TCT 2018 | FAST-FFR: FFR derivado de la angiografía, sin hiperemia y sin necesidad de cruzar la lesiónThis spurred the emergence of fractional flow reserve (FFR) derived from coronary angiography, and this work (presented at TCT 2018 and published simultaneously in Circulation) tries to determine the specific diagnostic capacity of this new method.

 

Coronary angiography was performed in lesions of varying severity, and then FFR was measured using a coronary pressure wire and hyperemic stimulus. At least two different projections were carried out, and on-site operators were blinded to FFR and calculated the angiography-derived FFR using proprietary software.


Read also: TCT 2018 | TriValve: Mitraclip for the Tricuspid Valve.


The primary endpoints were the sensitivity and specificity of the new method vs. standard invasive FFR using a cutoff value of 0.80.

 

A total of 301 patients and 319 vessels were assessed in 10 centers in the United States, Europe, and Israel. The mean FFR was 0.81 and 43% of vessels had values ≤0.8.


Read also: TCT 2018 | SOLVE-TAVI: Self-Expandable vs. Balloon-Expandable Valves and General vs. Local Anesthesia in One Study.


New method sensitivity and specificity were 94% (95% confidence interval [CI]: 88% to 97%) and 91% (95% CI: 86% to 95%), respectively. Both exceeded pre-specified performance goals.

 

Original title: Accuracy of Fractional Flow Reserve Derived from Coronary Angiography.

Presenter: William F. Fearon.

 

FAST-FFR-presentación

FAST-FFR-artículo-original


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....